Why the study?
Pediatric oncology patients experience high rates of hospital readmission, but research into risk factors for unplanned 30-day readmissions in this population is lacking.
Population
10 418 pediatric oncology patients across 32 667 encounters from 16 hospitals
Comparison
Risk factors for unplanned readmissions
Design
Multicenter database analysis and statistical modeling study
Follow-up
30 days
Key result
A mixed-effects model identified specific cancer types, chemotherapy, and cancer medications as risk factors for unplanned 30-day readmissions, achieving an AUC of 0.714 (95% CI 0.702-0.725).
Authors
Loading...
May inform readmission risk stratification in pediatric oncology; hypothesis-generating and requires prospective validation.
Observational (n=10,418)
Yes
Effect estimate: AUC 0.714 (95% CI 0.702-0.725)
Specific cancer types and chemotherapy administration are significant risk factors for unplanned 30-day readmissions in pediatric oncology patients.
Hoenk et al. (2021) conducted an observational in Pediatric oncology (n=10,418). Specific cancer types, chemotherapy, and cancer medications was evaluated on Unplanned 30-day readmission (AUC 0.714, 95% CI 0.702-0.725). A mixed-effects model identified specific cancer types, chemotherapy, and cancer medications as risk factors for unplanned 30-day readmissions, achieving an AUC of 0.714 (95% CI 0.702-0.725).